Drug Channels

FEBRUARY 7, 2024

As you will see, retail and mail prescription drug spending remain a consistently small share of the $4.5 And contrary to what you might read, drug spending growth was *not* driven by purportedly “skyrocketing” drug prices. Will drug pricing flat earthers (#DPFE) ever acknowledge the data? (Links below.) healthcare.

Pharmaceutical Companies 98

Pharmaceutical Companies Drugs Pharmaceuticals Trials 98

Drug Channels

OCTOBER 9, 2024

As regular readers of Drug Channels know, U.S. distribution and dispensing channels for prescription drugs are undergoing significant evolution and consolidation as the changing economics of pharmaceuticals challenge conventional business models. drug wholesaling industry. All rights reserved.

Pharmacy 98

Pharmacy Drugs Pharmaceuticals Hospitals 98

Drug Channels

JUNE 29, 2022

Through the Drug Channels Institute, I strive to provide you with fact-based and balanced coverage—along with links to source materials so you can make up your own mind. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Pharmacy 98

Pharmacy Drugs 98

Drug Channels

FEBRUARY 16, 2024

Gavin discusses the problems manufacturers face in accessing and standardizing drug discount data. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. These data are necessary to avoid duplicate discounts and comply with regulatory requirements. Read on for Gavin’s insights.

Drugs 98

Drugs 98

Drug Channels

SEPTEMBER 23, 2022

Lindsey describes the challenges facing remote workers who manage government-managed drug discount programs. As she explains, all drug discount stakeholders require novel technology-enabled collaboration tools. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Drugs 97

Drugs Government 97

Drug Channels

JANUARY 4, 2024

Paula and I have some exciting news to share with you: Drug Channels Institute is joining the HMP Global family! Here’s the press release: HMP Global Expands Market Reach with Strategic Acquisition of Drug Channels Institute; Launches Market Intelligence Unit Paula and I will continue to lead DCI as part of HMP.

Drugs 97

Drugs Marketing 97

Drug Channels

FEBRUARY 27, 2024

In this issue: An update on the retail pharmacy shakeout Arguing for high drug prices A leading researcher provides a 340B reality check Physicians don’t want pharmacists getting uppity Plus, Dave Grohl fights for your right to…have healthcare price transparency? (I Sorry, no Threads.) All rights reserved.

Pharmacy 95

Pharmacy Drugs Research International 95

Drug Channels

FEBRUARY 14, 2023

This Valentine's Day, what could be more romantic than a deep dive into the relationships between manufacturers of specialty drugs and the pharmacies they choose for their limited and exclusive specialty pharmacy networks. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Pharmacy 97

Pharmacy Specialty Pharmacies Drugs Production 97

Drug Channels

APRIL 8, 2024

I am pleased to announce the inaugural Drug Channels Leadership Forum ! The Leadership Forum will be an executive gathering where drug channel leaders can network and discuss key issues and challenges facing the commercial healthcare system. And of course, I'll be there to moderate the entire event and lead the fireside chats.

Pharmacy 97

Pharmacy Drugs Government Pharmaceuticals 97

Drug Channels

DECEMBER 5, 2023

Consider two apparently unrelated drug channel anomalies: In McKesson’s 2023 fiscal year, CVS bought $75 billion in pharmaceuticals from McKesson’s wholesale business—a jump of more than 35% compared with the previous year. Despite skyrocketing sales for anti-obesity GLP-1 drugs, many retail pharmacies are losing money on every prescription.

Pharmacy 98

Pharmacy Drugs Hospitals Pharmaceuticals 98

Drug Channels

DECEMBER 13, 2024

This week, Im rerunning some popular posts while I prepare for todays Drug Channels Outlook 2025 live video webinar. (If As you will see below, CMS projects that outpatient prescription drugs dispensed by retail and mail pharmacies will remain a small share of total U.S. If you sign up before 12 p.m. ET, you can attend the live event.)

Government 98

Government Specialty Pharmacies Pharmacy Drugs 98

Drug Channels

APRIL 21, 2022

By reader request, we present below a channel flow chart illustrating the buy-and-bill process for provider-administered drugs. Pharmacy Distribution and Reimbursement System for Patient-Administered, Outpatient Brand-name Drugs. The video is excerpted from my recent Drug Channels Update: Buy-and-Bill Trends video webinar.

Pharmacy 98

Pharmacy Drugs Pharmaceuticals Hospitals 98

Drug Channels

MAY 30, 2022

Let’s turn up the heat with these sizzling news bites straight from the Drug Channels grill: SaveonSP gets sued Thoughts on the Medicaid accumulator rule opinion CVS buys AmerisourceBergen’s specialty pharmacy Fresh data on hospitals’ cancer drug profiteering Plus, Dr. Glaucomflecken explains Aetna’s prior authorization policies.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Hospitals Drugs 97

Drug Channels

MAY 18, 2023

Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. You can also visit [link]. Read on for Patrick’s insights. This Feed is for personal non-commercial use only.

Drugs 98

Drugs Pharmaceuticals 98

Drug Channels

JANUARY 16, 2024

My recent Drug Channels Outlook 2024 webinar covered 12 key trends that will shape the commercial environment this year. The video excerpt below highlights my commentary on trend #2: the rapid growth of anti-obesity GLP-1 agonist drugs. Click here to sign up for The Drug Channels 2024 Video Webinar Series.

Pharmacy 98

Pharmacy Drugs Production 98

Drug Channels

JULY 5, 2022

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. This event is part of The Drug Channels 2022 Video Webinar Series. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Pharmacy 98

Pharmacy Drugs Marketing 98

Drug Channels

APRIL 12, 2022

As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. One bright spot: consumers will account for an ever-smaller share of drug spending. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

JUNE 14, 2022

Last week, the authors of a new JAMA study claimed that “prices for new drugs are skyrocketing.” Most notably, the authors discount the fact that the most expensive new drugs treat ultra-rare conditions affecting extraordinarily small patient populations. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. Links below.

Drugs 98

Drugs Disease Pharmaceuticals Treatment 98

Drug Channels

SEPTEMBER 14, 2022

These live, interactive events will be broadcast via Zoom from the Drug Channels Video studio in beautiful downtown Philadelphia. drug channel. Click here to order the Drug Channels 2023 Video Webinar Series. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Drugs 97

Drugs Marketing 97

Drug Channels

FEBRUARY 21, 2024

Below, I explain why the IRA will encourage Part D plans to prefer high-list, high-rebate specialty drugs , even as the government and manufacturers will prefer a low-list-price version. As always, I encourage you to share your own thoughts with the Drug Channels community on social media. Actually, maybe not. P.S. Want to learn more?

Biosimilars 98

Biosimilars Drugs Government Production 98

Drug Channels

JULY 29, 2022

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Specialty Drugs Update: Trends, Controversies, and Outlook. As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. healthcare spending.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

JANUARY 4, 2023

Time for the Drug Channels annual reality check on drug pricing. For 2022, brand-name drugs’ net prices dropped for an unprecedented fifth consecutive year. What’s more, after adjusting for overall inflation, brand-name drug net prices plunged by almost 9%. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Drugs 98

Drugs 98

Drug Channels

AUGUST 8, 2023

Click here to read the Drug Channels Institute letter to Senators Thune, Stabenow, Moore Capito, Baldwin, Moran, and Cardin. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. I shared my $0.02 How could I not?

Pharmacy 96

Pharmacy Hospitals Drugs Pharmaceuticals 96

Drug Channels

NOVEMBER 9, 2022

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for a new live video webinar: Drug Channels Outlook 2023. The webinar will be broadcast from the Drug Channels studio in beautiful downtown Philadelphia. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Biosimilars Drugs 98

Drug Channels

DECEMBER 20, 2022

Drug Channels also had a big 2022. I’ve had a blast writing Drug Channels and hope that you had fun reading it. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc.

Pharmacy 97

Pharmacy Drugs 97

Drug Channels

JULY 20, 2022

Join me next week for my new live video webinar, Specialty Drugs Update: Trends, Controversies, and Outlook , on July 29, 2022, from 12:00 p.m. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. to 1:30 p.m.

Biosimilars 98

Biosimilars Pharmacy Drugs Marketing 98

Drug Channels

MARCH 21, 2023

Spring is here in sunny downtown Philadelphia, worldwide headquarters of Drug Channels. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. to 1:30 p.m. Click here to learn more and sign up.

Pharmacy 98

Pharmacy Drugs 98

Drug Channels

OCTOBER 31, 2023

It's time for a super-sized Halloween roundup of wicked Drug Channels ’ tales. The gross-to-net bubble for anti-obesity GLP-1 drugs walks among us. Mark Cuban Cost Plus Drug Company conjures a partnership with Alto Pharmacy. Plus, an epic meetup with two of my favorite drug channel experts.

Biosimilars 98

Biosimilars Pharmacy Drugs 98

Drug Channels

NOVEMBER 28, 2023

In this issue: A reality check on Express Scripts’ purported “cost-based” pharmacy network Mark Cuban explains how and why the PBM market will change Why two drug prices are better than one Pharmacists sing the retail pharmacy shakeout blues Plus, two Philly legends meet at a cardiology conference! d/b/a Drug Channels Institute.

Pharmacy 97

Pharmacy Drugs Marketing 97

Drug Channels

APRIL 5, 2024

This week, I’m rerunning some popular posts while I prepare for today’s live video webinar: Drug Channel Implications of the Inflation Reduction Act. Thanks to the IRA, Part D Plans Will Prefer High-List, High-Rebate Drugs. It's time for Drug Channels ’ annual reality check on U.S. drug pricing. Details below.

Drugs 94

Drugs Government Production 94

Drug Channels

MARCH 31, 2023

Time for the Drug Channels annual reality check on drug pricing. For 2022, brand-name drugs’ net prices dropped for an unprecedented fifth consecutive year. What’s more, after adjusting for overall inflation, brand-name drug net prices plunged by almost 9%. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Pharmacy 97

Pharmacy Drugs 97

Drug Channels

NOVEMBER 14, 2023

Fein, CEO of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live video webinar: Drug Channels Outlook 2024 This event will be broadcast live on Friday, December 15, 2023 12:00 p.m. This event is part of The Drug Channels 2023 Video Webinar Series. Dr. Adam J.

Pharmacy 98

Pharmacy Drugs Biosimilars Marketing 98

Drug Channels

JANUARY 3, 2024

It's time for Drug Channels ’ annual reality check on U.S. drug pricing. For 2023, brand-name drugs’ list prices again grew at mid-single-digit rates. What’s more, after adjusting for overall inflation, brand-name drug net prices plunged by more than 7%. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc.

Drugs 97

Drugs Government 97

Drug Channels

MARCH 6, 2023

Experts from across the industry will discuss how current and future drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices. Drug Channels readers will save 10% off when they use code 23DRCH10 and register prior to March 31, 2023.*

Drugs 98

Drugs Compliance Science Government 98

Drug Channels

APRIL 16, 2024

Drug Channels Institute’s (DCI’s) latest analysis finds that participants in the specialty pharmacy market continue to get more diverse—although revenues remain highly concentrated. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Specialty Pharmacies 96

Specialty Pharmacies Pharmacy Marketing Hospitals 96

Drug Channels

APRIL 26, 2022

Read more » Copyright © 2006-2022 Pembroke Consulting, Inc. d/b/a Drug Channels Institute. Drug Channels® is a registered trademark of Pembroke Consulting, Inc. Scott Gottlieb for a fireside chat at 8:00 AM and will then present my "State of Specialty Pharmacy 2022" at 9:30 AM. Hope to see you there!

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Doctors Drugs 98

Drug Channels

APRIL 9, 2024

Read on for Drug Channels Institute’s (DCI’s) latest market share figures, along with a preview of the industry changes that will shift these shares over the next few years. Read more » © 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Pharmacy 98

Pharmacy Marketing Drugs 98